Literature DB >> 8487489

Controlled diet in phenylketonuria may cause serum carnitine deficiency.

M A Vilaseca1, P Briones, I Ferrer, J Campistol, A Riverola, P Castillo, F Ramon.   

Abstract

Serum carnitine levels may be reduced in patients with phenylketonuria (PKU) owing to low carnitine intake, deficient carnitine synthesis and acylcarnitine production from phenylalanine metabolites. In order to investigate the possible carnitine deficiency we determined serum carnitine in its different forms and the precursors and cofactors involved in its synthesis in a group of patients with PKU or hyperphenylalaninaemia. Free, total and acylcarnitine values were significatively reduced only in PKU patients with Phe-restricted diet which had not been supplemented with carnitine. Acylcarnitine/free carnitine ratio and all the other parameters studied were normal in all patients. We conclude that the low serum carnitine levels in PKU patients with a strict diet are a consequence of the low carnitine intake.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8487489     DOI: 10.1007/bf00711322

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  6 in total

1.  Serum carnitine level in phenylketonuric children under dietary control in Greece.

Authors:  K H Schulpis; C Nounopoulos; A Scarpalezou; A Bouloukos; S Missiou-Tsagarakis
Journal:  Acta Paediatr Scand       Date:  1990-10

2.  Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.

Authors:  Y Ohtani; K Ohyanagi; S Yamamoto; I Matsuda
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

3.  Inadequate iron availability as a possible cause of low serum carnitine concentrations in patients with phenylketonuria.

Authors:  H Böhles; K Ullrich; W Endres; A W Behbehani; U Wendel
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

4.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.

Authors:  P G Barth; H R Scholte; J A Berden; J M Van der Klei-Van Moorsel; I E Luyt-Houwen; E T Van 't Veer-Korthof; J J Van der Harten; M A Sobotka-Plojhar
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

5.  A case of carbamylphosphate synthetase-I deficiency associated with secondary carnitine deficiency--L-carnitine treatment of CPS-I deficiency.

Authors:  T Mori; A Tsuchiyama; K Nagai; M Nagao; K Oyanagi; S Tsugawa
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

6.  Study of serum ferritin in 58 children with classic phenylketonuria and persistent hyperphenylalaninaemia.

Authors:  S Scaglioni; G Zuccotti; M Vedovello; A Rottoli; S Paccanelli; R Longhi; E Riva; M Giovannini
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

  6 in total
  3 in total

1.  L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Jurema F de Mari; Amanda T Barden; Camila S Vanzin; Giovana B Biancini; Ida V D Schwartz; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2008-09-24       Impact factor: 5.046

2.  Assessment of the Phenylketonuria (PKU)-Associated Mutation p.R155H Biochemical Manifestations by Mass Spectrometry-Based Blood Metabolite Profiling.

Authors:  O A Baturina; A A Chernonosov; V V Koval; I V Morozov
Journal:  Acta Naturae       Date:  2019 Apr-Jun       Impact factor: 1.845

3.  Metabolomics of dietary fatty acid restriction in patients with phenylketonuria.

Authors:  Ulrike Mütze; Skadi Beblo; Linda Kortz; Claudia Matthies; Berthold Koletzko; Mathias Bruegel; Carmen Rohde; Joachim Thiery; Wieland Kiess; Uta Ceglarek
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.